Thiazolidine-2,4-dione compound and method of treatment of diabetic complications
US5225426A · kind A · utility
6Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 1991 |
| Grant date | Jul 6, 1993 |
| Priority date | — |
| Expiry date | Dec 4, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel compound is proposed which is effective in curing various complications as with catarat, retinopathy, neurotic disorder, and renal disorder. The thiazolidine-2,4-dione compound represented by the following general formula I combines an action to inhibit aldose reductase and an action to depress blood sugar and manifests an efficacy in the cure of various complications as with catarat, retinopathy, neurotic disorder, and renal disorder. ##STR1## wherein R.sup.1 is a hydrogen atom or a methyl group.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.